| Renal Cell Cancer | |
|
We currently are not conducting clinical trials for this category in which we are seeking participants. Please check back as this is frequently updated. Ongoing Clinical Trials Trial Status CLOSED TO ENROLLMENT Protocol Number: WX-2003-07-HR 07/2007 - Present Sponsor: Wilex Title: A randomized double blind phase III study to evaluate adjuvant cG250 treatment versus placebo in patients with clear cell RCC and high risk of recurrence. Purpose of Study We are currently conducting a study to evaluate the efficacy and safety of a medication treatment versus placebo (sugar pill) in clear cell Renal Cell Carcinoma (RCC) patients after surgery with no evidence of residual disease and with a high risk of recurrence. The main objective is to evaluate the treatment by assessing the disease-free survival and overall survival in the subjects taking medication compared to the placebo (sugar pill) and the impact on the quality of life. For further information click here. Clinical Research Coordinators: Patricia Edwards, RN (336) 274-1114 ext. 5322 Karen Michael, RN (336) 274-1114 ext. 5328 E-mail address: research@allianceurology.com |
|
All trademarks and registered trademarks are of their respective companies.
Site powered by Medfusion, Inc.
Website Graphics by Vintage Marketing